• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS NUSSLOCH GMBH HISTOCORE PEGASUS PLUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS NUSSLOCH GMBH HISTOCORE PEGASUS PLUS Back to Search Results
Catalog Number 14048858007
Device Problem Insufficient Information (3190)
Patient Problem Tissue Breakdown (2681)
Event Date 02/21/2023
Event Type  Injury  
Manufacturer Narrative
An investigation of the incident is currently underway and a follow up will be submitted should additional information become available following the investigation.
 
Event Description
On 21 february 2023 leica biosystems received a complaint that the customer experienced suboptimal tissue processing on their histocore pegasus plus.On 03 march 2023 the customer informed leica biosystems, that as a result, 1 tissue skin sample has not been diagnosed.
 
Manufacturer Narrative
Correction: the "establishment name" was incorrect in the initial report.The "establishment name" is "laboratoire kowalski gringnon depardieu".
 
Manufacturer Narrative
The investigation revealed the following: the instrument logs were analyzed by the lbs senior quality engineer and no instrument error was detected during the processing steps related to the damaged tissue.Furthermore, the affected instrument was sent back to nussloch for an additional investigation with result, that no malfunction of the instrument has been found.The incident was user related due to an incorrect usage of the processing protocol and carryover settings, because the tissues and biopsies were processed together with an overnight protocol.The carryover setting is a setting for a protocol, not for a specific run, so it must be set to the average carryover value for runs that use that protocol.The carryover is dependent on the types of cassettes and other small-tissue carriers used: biopsy pads, paper or tissue inserts, mini cassettes, biopsy cassettes, etc.It also depends on the proportion of these in each run.Therefore, the protocol setup depends on the processed tissues, and therefore different protocol and carryover settings need to be selected.A customer facing letter will be sent out to the customer with recommendation, to consider the carryover setting and to use the recommended accordingly the protocol for standard biopsy and small specimen as defined in the instruction for use (ifu).
 
Manufacturer Narrative
Additional information: added unique identifier (udi) # in d4.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HISTOCORE PEGASUS PLUS
Type of Device
HISTOCORE PEGASUS PLUS
Manufacturer (Section D)
LEICA BIOSYSTEMS NUSSLOCH GMBH
heidelbergerstrasse 17-19
nussloch, 69226
GM  69226
Manufacturer (Section G)
LEICA MICROSYSTEMS LTD. SHANGHAI
building 1, 258 jinzang road
shanghai,pudong, 20120 6
CH   201206
Manufacturer Contact
robert gropp
heidelbergerstr. 17-19
nussloch, 69226
GM   69226
MDR Report Key16654404
MDR Text Key312407650
Report Number8010478-2023-00003
Device Sequence Number1
Product Code IEO
UDI-Device Identifier04049188217769
UDI-Public(01)04049188217769
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 10/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number14048858007
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/03/2023
Initial Date FDA Received03/31/2023
Supplement Dates Manufacturer Received06/13/2023
06/13/2023
06/13/2023
Supplement Dates FDA Received06/19/2023
06/21/2023
10/30/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/05/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-